UPDATE 1-Tesaro's ovarian cancer drug benefits all patients in study
October 08, 2016 at 04:33 AM EDT
* Patients negative to Myriad HRD diagnostic test also benefit
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.